Last reviewed · How we verify
NCT04924907
Lifestyles, Arterial Aging and Intestinal Microbiota (MIVAS III Study)
trial in Arterial Stiffness in 1,015 participants. Completed in 31 December 2023.
30 December 2023
Quick facts
| Lead sponsor | Instituto de Investigación Biomédica de Salamanca |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,015 |
| Start date | 21 April 2021 |
| Primary completion | 30 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 2 locations across Spain |
Conditions studied
- Arterial Stiffness — all drugs for Arterial Stiffness →
- Dysbiosis — all drugs for Dysbiosis →
Sponsor
Instituto de Investigación Biomédica de Salamanca — full company profile →
Who can join
Adults 45 to 74, any sex, with Arterial Stiffness or Dysbiosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational cross-sectional study whose objective is to analyse associations between the intestinal and salivate microbiota with lifestyles (eating patterns, physical activity, tobacco and alcohol consumption), arterial aging and cognitive function. It will take place in five different research units located in Spain
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lifestyles, arterial aging, and its relationship with the intestinal and oral microbiota (MIVAS III study): a research protocol for a cross-sectional multicenter study.
Lugones-Sánchez C, Santos-Mínguez S, Salvado R, González-Sánchez S, et al · · 2023 · cited 4× · PMID 37457284 · DOI 10.3389/fpubh.2023.1164453
Verify or expand the search:
- PubMed search for NCT04924907
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arterial Stiffness
Currently open trials in the same condition.
- NCT07070778 — Arterial Stiffness in Individuals With Breast Cancer · NA · recruiting
- NCT06885970 — The Effect of Cytisine Treatment for Smoking Cessation on Cardiovascular Function in Adult Smokers · recruiting
- NCT07324902 — The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation · recruiting
- NCT06735651 — Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes · NA · recruiting
- NCT06735599 — Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure · NA · recruiting
Other Instituto de Investigación Biomédica de Salamanca trials
Trials by the same sponsor.
- NCT07015892 — Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial · Phase 3 · recruiting
- NCT07195331 — Comparison Between Standard and Reduced Doses of Indocyanine Green in Fluorescence Cholangiography During Laparoscopic C · Phase 4 · recruiting
- NCT06977295 — Evaluation of a Diagnostic Software for Coronary Artery Disease Using Retrospective CCTA Data (CODEX-1 Study) · active not recruiting
- NCT06382844 — Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL · recruiting
- NCT06379945 — Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personal · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04924907 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigación Biomédica de Salamanca
- Last refreshed: 31 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04924907.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing